Data presented at the AAN Annual meeting have shown improvements in both presymptomatic infants and children with later-onset spinal muscular atrophy when assigned to FDA-approved treatment
A small, preliminary study investigating the relationship between multiple sclerosis and the Epstein-Barr virus suggests a potential novel treatment for progressive multiple sclerosis.
An evaluation of ‘IL4I1 augments CNS remyelination and axonal protection by modulating T-cell driven inflammation’, recently published in Brain.
The article reviews current literature on the use of adoptive immunotherapy for malignant gliomas as well as the
the concept of antitumor activity mediated by CIK cells.
This Editorial article provides an insight into how pharmacogenomics can assist in guided dosing of fentanyl for the treatment of pain.